AFYREN AI Stock Analysis
Want to see FR:ALAFY full AI Analyst Report?
AFYREN (ALAFY) AI Stock Analysis
AFYREN
(Paris:ALAFY)
The overall score is driven primarily by weak fundamentals: persistent revenue decline, negative margins, and worsening cash flows despite a solid, low-leverage balance sheet. Secondary pressure comes from mildly bearish technicals, with the price below major moving averages and modestly weak momentum. Valuation contributes modestly to the low score, as losses and the absence of a dividend limit valuation appeal based on the available metrics.
AFYREN (ALAFY) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 86.64M
- Dividend Yield
- ―
- Average Volume (3M)
- 10.67K
- Price to Earnings (P/E)
- -11.3
- Beta (1Y)
- 0.01
- Revenue Growth
- -13.62%
- EPS Growth
- 54.46%
- Country
- France
- Employees
- 149
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
AFYREN Business Overview & Revenue Model
Company Description
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lubric...
AFYREN Financial Statement Overview
Summary
Financial performance is weak overall: revenues are declining, margins are deeply negative, and net losses and operating cash burn are widening, partly offset by a deleveraged balance sheet and stable equity.
Income Statement
28NegativeBalance Sheet
72PositiveCash Flow
35Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.33M | 2.27M | 2.86M | 3.38M | 3.46M | 3.04M |
| Gross Profit | -10.71M | -5.49M | -174.00K | 645.00K | 1.06M | 1.47M |
| EBITDA | -11.42M | -6.81M | -8.81M | -8.59M | -4.71M | -2.78M |
| Net Income | -5.01M | -14.37M | -9.75M | -9.59M | -9.20M | -3.61M |
Balance Sheet | ||||||
| Total Assets | 139.25M | 67.14M | 58.56M | 70.43M | 84.82M | 93.15M |
| Cash, Cash Equivalents and Short-Term Investments | 17.30M | 35.16M | 33.65M | 49.66M | 62.40M | 67.36M |
| Total Debt | 40.90M | 2.42M | 3.31M | 4.79M | 8.54M | 8.95M |
| Total Liabilities | 67.49M | 4.19M | 5.86M | 8.63M | 13.84M | 15.29M |
| Stockholders Equity | 71.76M | 62.10M | 52.70M | 61.80M | 70.98M | 77.86M |
Cash Flow | ||||||
| Free Cash Flow | -15.31M | -5.29M | -5.84M | -5.60M | -3.83M | -3.06M |
| Operating Cash Flow | -9.84M | -5.09M | -5.62M | -5.04M | -3.30M | -2.71M |
| Investing Cash Flow | -27.49M | -15.25M | -9.11M | -3.08M | -362.00K | -436.00K |
| Financing Cash Flow | 27.17M | 21.96M | -1.28M | -4.66M | -1.14M | 60.77M |
AFYREN Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAFY, the sentiment is Negative. The current price of 2.23 is below the 20-day moving average (MA) of 2.24, below the 50-day MA of 2.39, and below the 200-day MA of 2.63, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 43.47 is Neutral, neither overbought nor oversold. The STOCH value of 58.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALAFY.
AFYREN Peers Comparison
Overall Rating
FR:AI68Neutral
FR:CBE63Neutral
FR:AKE60Neutral
FR:ALBKK55Neutral
FR:ALAFY45.3Neutral
FR:ALCRB41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | EUR 120.85B | 32.49 | 13.42% | 1.61% | -1.30% | 3.05% | |
| 63Neutral | EUR 1.62B | 16.54 | ― | 1.94% | 0.30% | 0.78% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 60Neutral | EUR 4.40B | 52.14 | 1.28% | 6.28% | -1.70% | -42.07% | |
| 55Neutral | EUR 70.46M | 42.67 | 3.51% | 1.56% | 6.97% | -73.50% | |
| 45Neutral | EUR 86.64M | -11.29 | -7.49% | ― | -13.62% | 54.46% | |
| 41Neutral | EUR 68.54M | -3.41 | -10.62% | ― | ― | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:ALAFY | AFYREN | 2.23 | 0.00 | 0.00% | |
| FR:AI | Air Liquide (UK) | 189.74 | 42.27 | 28.66% | |
| FR:AKE | Arkema SA (UK) | 57.35 | 10.45 | 22.29% | |
| FR:ALCRB | Carbios SA | 4.05 | -5.10 | -55.68% | |
| FR:ALBKK | Baikowski SA | 19.20 | -3.33 | -14.77% | |
| FR:CBE | Robertet SA Cert.d'Invest. Em.87 | 620.00 | -101.93 | -14.12% |
AFYREN Corporate Events
AFYREN and MINASOLVE Partner on Bio-Based Fragrance Molecules
AFYREN is a French greentech company using proprietary fermentation technology and non-food agricultural co-products to make bio-based, low-carbon carboxylic acids. Its solutions serve manufacturers in nutrition, flavors and fragrances, life sciences...
AFYREN’s biosourced propionic acid powers first-of-its-kind skincare launch
AFYREN is reinforcing its role in sustainable industrial biotechnology by supplying 100% biosourced, COSMOS‑certified propionic acid produced via a low‑carbon, circular fermentation process at its AFYREN NEOXY biorefinery in France. The company focus...
AFYREN and Terrial Renew Multi‑Year Potassium Fertilizer Alliance
AFYREN and Terrial have renewed their strategic partnership with a new multi‑year fertilizer supply contract worth several tens of millions of euros, centered on AFYREN’s potassium‑rich fertilizer processed by Terrial and marketed in France under the...
AFYREN Takes Full Control of Flagship Plant as Production and Pre-Sold Volumes Surge
AFYREN has strengthened its industrial profile by acquiring the remaining 49% of its AFYREN NEOXY plant, becoming its sole owner and gaining full control over ramp-up and performance investments. The company successfully executed an optimization prog...
AFYREN scales bio-based acid output and strengthens climate-resilient positioning
AFYREN has crossed the milestone of 1,000 tonnes of bio-based acids produced at its AFYREN NEOXY biorefinery since ramp-up began in mid-2025, including more than 200 tonnes since operations resumed in July 2026, signalling its transition to full indu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 17, 2026
